TherapeuticsMD Announces 2023 Annual Financial Results
PremiumCompany AnnouncementsTherapeuticsMD Announces 2023 Annual Financial Results
8M ago
60 Degrees Pharmaceuticals appoints Kristen Landon as CCO
Premium
The Fly
60 Degrees Pharmaceuticals appoints Kristen Landon as CCO
9M ago
Knight Therapeutics announces launch for IMVEXXY in Canada
Premium
The Fly
Knight Therapeutics announces launch for IMVEXXY in Canada
10M ago
TherapeuticsMD enters agreements to license products to Mayne Pharma
PremiumThe FlyTherapeuticsMD enters agreements to license products to Mayne Pharma
2y ago
TherapeuticsMD reports Q3 EPS ($3.13) vs. ($5.62) a year ago
Premium
The Fly
TherapeuticsMD reports Q3 EPS ($3.13) vs. ($5.62) a year ago
2y ago
Leading Insider Makes Private Investment in TherapeuticsMD Worth $15M
Premium
Market News
Leading Insider Makes Private Investment in TherapeuticsMD Worth $15M
2y ago
EW Healthcare Partners Acquires TherapeuticsMD; TXMD Shares Surge 350%
PremiumMarket NewsEW Healthcare Partners Acquires TherapeuticsMD; TXMD Shares Surge 350%
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100